Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CARU disapproves of Orajel ad

This article was originally published in The Tan Sheet

Executive Summary

Church & Dwight will discontinue ads for Orajel Toddler Training Toothpaste during children's programming hours in response to concerns the Children's Advertising Review Unit expressed in its routine monitoring program. The Council of Better Business Bureaus division says Dec. 10 that the product's "Keep out of the reach of children" label makes advertising directly to children inappropriate. In November, CARU made a similar decision for Johnson & Johnson's Clean & Clear ad on Nickelodeon (1"The Tan Sheet" Dec. 1, 2008, p. 16). C&D says that with its April acquisition of Del Pharmaceuticals' OTC brands, including Orajel, it assumed the advertising placement schedules (2"The Tan Sheet" April 7, 2008, p. 3). In the commercial, a child brushes his teeth while a voice outlines the benefits of Orajel toothpaste. CARU says there is no parental presence or adult supervision

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102403

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel